
Senior Clinical Research Associate with extensive international experience (France, UK, Australia). Expertise in oncology (Phases I–III) and vaccines, from selection to closure, regulatory compliance, Good Clinical Practice (GCP), RECIST 1.0, TMF/eTMF, clinical team coordination, and budget management. Rigorous and quality-oriented approach with a strong sense of priorities.
Oncology Phases I–II
• Full site oversight (selection to close-out)
• On-site and remote monitoring
• SDV / SDR - RECIST 1.0
• Pharmacy and IP stock management
• Biological sample shipment tracking
• Ethics submissions
• PV and CAPA management
• TMF / eTMF
COVID-19 studies (Novavax Vaccine Phase III)
• Site feasibility and selection
• EDC monitoring (SDV / SDR)
• eTMF
• Pharmacy and stock management
• Pharmacy and stock management
• RTSM
• EDC
• Site training and oversight
• ICH-GCP compliance